Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders

Abstract Background Women with adenomyosis are characterized by having defective decidualization, impaired endometrial receptivity and/or embryo-maternal communication, and implantation failure. However, the molecular mechanisms underlying adenomyosis-related infertility remain unknown, mainly becau...

Full description

Bibliographic Details
Main Authors: Elena Juárez-Barber, Ana Corachán, María Cristina Carbajo-García, Amparo Faus, Carmen Vidal, Juan Giles, Antonio Pellicer, Irene Cervelló, Hortensia Ferrero
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Reproductive Biology and Endocrinology
Subjects:
Online Access:https://doi.org/10.1186/s12958-023-01182-7
_version_ 1797355451497578496
author Elena Juárez-Barber
Ana Corachán
María Cristina Carbajo-García
Amparo Faus
Carmen Vidal
Juan Giles
Antonio Pellicer
Irene Cervelló
Hortensia Ferrero
author_facet Elena Juárez-Barber
Ana Corachán
María Cristina Carbajo-García
Amparo Faus
Carmen Vidal
Juan Giles
Antonio Pellicer
Irene Cervelló
Hortensia Ferrero
author_sort Elena Juárez-Barber
collection DOAJ
description Abstract Background Women with adenomyosis are characterized by having defective decidualization, impaired endometrial receptivity and/or embryo-maternal communication, and implantation failure. However, the molecular mechanisms underlying adenomyosis-related infertility remain unknown, mainly because of the restricted accessibility and the difficult preservation of endometrial tissue in vitro. We have recently shown that adenomyosis patient-derived endometrial organoids, maintain disease-specific features while differentiated into mid-secretory and gestational endometrial phase, overcoming these research barriers and providing a robust platform to study adenomyosis pathogenesis and the associated molecular dysregulation related to implantation and pregnancy disorders. For this reason, we aim to characterize the dysregulated mechanisms in the mid-secretory and gestational endometrium of patients with adenomyosis by RNA-sequencing. Methods Endometrial organoids were derived from endometrial biopsies collected in the proliferative phase of women with adenomyosis (ADENO) or healthy oocyte donors (CONTROL) (n = 15/group) and differentiated into mid-secretory (-SECorg) and gestational (-GESTorg) phases in vitro. Following RNA-sequencing, the significantly differentially expressed genes (DEGs) (FDR < 0.05) were identified and selected for subsequent functional enrichment analysis and QIAGEN Ingenuity Pathway Analysis (IPA). Statistical differences in gene expression were evaluated with the Student’s t-test or Wilcoxon test. Results We identified 1,430 DEGs in ADENO-SECorg and 1,999 DEGs in ADENO-GESTorg. In ADENO-SECorg, upregulated genes included OLFM1, FXYD5, and RUNX2, which are involved in impaired endometrial receptivity and implantation failure, while downregulated genes included RRM2, SOSTDC1, and CHAC2 implicated in recurrent implantation failure. In ADENO-GESTorg, upregulated CXCL14 and CYP24A1 and downregulated PGR were related to pregnancy loss. IPA predicted a significant inhibition of ID1 signaling, histamine degradation, and activation of HMGB1 and Senescence pathways, which are related to implantation failure. Alternatively, IPA predicted an inhibition of D-myo-inositol biosynthesis and VEGF signaling, and upregulation of Rho pathway, which are related to pregnancy loss and preeclampsia. Conclusions Identifying dysregulated molecular mechanisms in mid-secretory and gestational endometrium of adenomyosis women contributes to the understanding of adenomyosis-related implantation failure and/or pregnancy disorders revealing potential therapeutic targets. Following experimental validation of our transcriptomic and in silico findings, our differentiated adenomyosis patient-derived organoids have the potential to provide a reliable platform for drug discovery, development, and personalized drug screening for affected patients.
first_indexed 2024-03-08T14:11:25Z
format Article
id doaj.art-a5a835e0d5954ef5bce4e15e83bea809
institution Directory Open Access Journal
issn 1477-7827
language English
last_indexed 2024-03-08T14:11:25Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Reproductive Biology and Endocrinology
spelling doaj.art-a5a835e0d5954ef5bce4e15e83bea8092024-01-14T12:42:48ZengBMCReproductive Biology and Endocrinology1477-78272024-01-0122111310.1186/s12958-023-01182-7Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disordersElena Juárez-Barber0Ana Corachán1María Cristina Carbajo-García2Amparo Faus3Carmen Vidal4Juan Giles5Antonio Pellicer6Irene Cervelló7Hortensia Ferrero8Fundación IVI, Instituto de Investigación Sanitaria La FeFundación IVI, Instituto de Investigación Sanitaria La FeFundación IVI, Instituto de Investigación Sanitaria La FeFundación IVI, Instituto de Investigación Sanitaria La FeIVI-RMA ValenciaIVI-RMA ValenciaFundación IVI, Instituto de Investigación Sanitaria La FeFundación IVI, Instituto de Investigación Sanitaria La FeFundación IVI, Instituto de Investigación Sanitaria La FeAbstract Background Women with adenomyosis are characterized by having defective decidualization, impaired endometrial receptivity and/or embryo-maternal communication, and implantation failure. However, the molecular mechanisms underlying adenomyosis-related infertility remain unknown, mainly because of the restricted accessibility and the difficult preservation of endometrial tissue in vitro. We have recently shown that adenomyosis patient-derived endometrial organoids, maintain disease-specific features while differentiated into mid-secretory and gestational endometrial phase, overcoming these research barriers and providing a robust platform to study adenomyosis pathogenesis and the associated molecular dysregulation related to implantation and pregnancy disorders. For this reason, we aim to characterize the dysregulated mechanisms in the mid-secretory and gestational endometrium of patients with adenomyosis by RNA-sequencing. Methods Endometrial organoids were derived from endometrial biopsies collected in the proliferative phase of women with adenomyosis (ADENO) or healthy oocyte donors (CONTROL) (n = 15/group) and differentiated into mid-secretory (-SECorg) and gestational (-GESTorg) phases in vitro. Following RNA-sequencing, the significantly differentially expressed genes (DEGs) (FDR < 0.05) were identified and selected for subsequent functional enrichment analysis and QIAGEN Ingenuity Pathway Analysis (IPA). Statistical differences in gene expression were evaluated with the Student’s t-test or Wilcoxon test. Results We identified 1,430 DEGs in ADENO-SECorg and 1,999 DEGs in ADENO-GESTorg. In ADENO-SECorg, upregulated genes included OLFM1, FXYD5, and RUNX2, which are involved in impaired endometrial receptivity and implantation failure, while downregulated genes included RRM2, SOSTDC1, and CHAC2 implicated in recurrent implantation failure. In ADENO-GESTorg, upregulated CXCL14 and CYP24A1 and downregulated PGR were related to pregnancy loss. IPA predicted a significant inhibition of ID1 signaling, histamine degradation, and activation of HMGB1 and Senescence pathways, which are related to implantation failure. Alternatively, IPA predicted an inhibition of D-myo-inositol biosynthesis and VEGF signaling, and upregulation of Rho pathway, which are related to pregnancy loss and preeclampsia. Conclusions Identifying dysregulated molecular mechanisms in mid-secretory and gestational endometrium of adenomyosis women contributes to the understanding of adenomyosis-related implantation failure and/or pregnancy disorders revealing potential therapeutic targets. Following experimental validation of our transcriptomic and in silico findings, our differentiated adenomyosis patient-derived organoids have the potential to provide a reliable platform for drug discovery, development, and personalized drug screening for affected patients.https://doi.org/10.1186/s12958-023-01182-7AdenomyosisEndometrial organoidsRNA-sequencingImplantation failurePregnancy lossInfertility
spellingShingle Elena Juárez-Barber
Ana Corachán
María Cristina Carbajo-García
Amparo Faus
Carmen Vidal
Juan Giles
Antonio Pellicer
Irene Cervelló
Hortensia Ferrero
Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders
Reproductive Biology and Endocrinology
Adenomyosis
Endometrial organoids
RNA-sequencing
Implantation failure
Pregnancy loss
Infertility
title Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders
title_full Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders
title_fullStr Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders
title_full_unstemmed Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders
title_short Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders
title_sort transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis related implantation failure and pregnancy disorders
topic Adenomyosis
Endometrial organoids
RNA-sequencing
Implantation failure
Pregnancy loss
Infertility
url https://doi.org/10.1186/s12958-023-01182-7
work_keys_str_mv AT elenajuarezbarber transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT anacorachan transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT mariacristinacarbajogarcia transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT amparofaus transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT carmenvidal transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT juangiles transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT antoniopellicer transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT irenecervello transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders
AT hortensiaferrero transcriptomeanalysisofadenomyosiseutopicendometriumrevealsmolecularmechanismsinvolvedinadenomyosisrelatedimplantationfailureandpregnancydisorders